TransUnion (TRU) to Sell TransUnion Healthcare to Clearlake Capital Group-Backed nThrive for $1.7 Billion
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St set for higher open as AI stocks rise, oil slides
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall St set for higher open as AI stocks rise, oil slides
- Streamflation drives 39% of Americans to cancel streaming in 6 months
TransUnion (TRU) Sells TransUnion Healthcare to Clearlake Capital's nThrive for $1.7B
October 26, 2021 6:24 AM EDTTransUnion (NYSE: TRU) has signed a definitive agreement to sell TransUnion Healthcare, Inc. (TransUnion Healthcare) to nThrive, Inc. (nThrive), a leading healthcare revenue cycle management (RCM) software-as-a-service (SaaS) platform backed by Clearlake Capital Group, L.P. (together with certain affiliates, Clearlake).
The transaction consideration is $1.735 billion in cash, and the transaction is expected to result in approximately $1.4 billion in after-tax proceeds at current tax... More
